Tag: UK Healthcare


  • Irish doctor dies in Manchester hospital after med error

    Irish doctor dies in Manchester hospital after med error

    Overview An inquest has revealed that an Irish doctor, who spent more than four decades practicing in Britain, died in a Manchester hospital after he was given the wrong medication for a chest infection. The coroner concluded that the medication error contributed to the cardiac arrest that followed. The case has sparked renewed discussion about…

  • Could low-dose CT scans replace chest X-rays for early lung cancer detection? MEDLEY study underway

    Could low-dose CT scans replace chest X-rays for early lung cancer detection? MEDLEY study underway

    New study aims to improve early detection of lung cancer A major new study, MEDLEY, is underway with recruitment in several UK cities. The project, funded by the National Institute for Health Research (NIHR), seeks to determine whether low-dose computed tomography (CT) scans can improve the early detection of lung cancers compared with the traditional…

  • Portlaoise Boy’s Landmark Gene Therapy Trial Delivers Life-Changing Results

    Portlaoise Boy’s Landmark Gene Therapy Trial Delivers Life-Changing Results

    Groundbreaking trial offers new hope for ADA-SCID patients The story of a nine-year-old boy from Portlaoise who took part in a landmark medical study has offered a beacon of hope for children with ADA-SCID, a rare and life-threatening immune deficiency. After being diagnosed just three weeks old, his family faced a long and difficult journey…

  • Heeding Sir John Bell’s Warning on Pharma Investments in the UK

    Heeding Sir John Bell’s Warning on Pharma Investments in the UK

    Introduction In recent discussions about the future of pharmaceutical research in the UK, Sir John Bell’s insights have raised critical concerns. His warning comes against the backdrop of Merck’s decision to close its proposed £1bn research center in King’s Cross, London. This decision highlights significant worries about the UK’s competitiveness in attracting global pharmaceutical investments.…

  • Impact of Big Pharma’s Withdrawal from UK Investments

    Impact of Big Pharma’s Withdrawal from UK Investments

    The Warning from Sir John Bell Sir John Bell, a key figure in the UK’s Covid-19 vaccine rollout, has recently sounded the alarm on the future of pharmaceutical investments in the UK. In light of Merck’s recent decision to halt a planned £1 billion investment in the country, Bell is concerned that other big pharmaceutical…